Mutation hotspots in the human porphobilinogen deaminase gene: Recurrent mutations G111R and R173Q occurring at CpG motifs
- 1 September 2004
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 27 (5) , 625-631
Abstract
Summary: Acute intermittent porphyria (AIP) is an inherited disorder in the haem biosynthetic pathway caused by a partial deficiency of porphobilinogen (PBG) deaminase. To date, more than 200 different mutations have been identified in the PBG deaminase gene (PBGD) in AIP patients from various countries and ethnic groups. While the majority of the PBGD gene mutations, including most of the mutations occurring at CpG dinucleotides, are family‐specific, a few CpG mutations have been observed in a number of AIP patients of European origin. To study the origin of these common CpG mutations, eight intragenic single‐nucleotide polymorphisms (SNPs) in the PBGD gene, as well as eight microsatellites flanking the gene in chromosome 11 were used to construct haplotypes in six AIP families of German, Polish and Swiss origins who carried either G111R (4707G>;A) or R173Q (6391G>;A) mutations. Among the three R173Q families, three distinct haplotypes were found to be cosegregated with the mutation. One Swiss and one German G111R family shared partially an intragenic and its extended microsatellite haplotype, whereas the Polish G111R family showed a unique haplotype. These results indicated that the recurrent CpG mutations that exist in the European AIP population can be either of ancestral origins or derived from de novo events.Keywords
This publication has 18 references indexed in Scilit:
- Molecular study of the hydroxymethlybilane synthase gene (HMBS) among Polish patients with acute intermittent porphyriaHuman Mutation, 2002
- Ancestral Founder of Mutation W283X in the Porphobilinogen Deaminase Gene among Acute Intermittent Porphyria PatientsHuman Heredity, 2002
- Influence of Age and Gender on the Clinical Expression of Acute Intermittent Porphyria Based on Molecular Study of Porphobilinogen Deaminase Gene Among Swiss PatientsMolecular Medicine, 2001
- Identification of a Prevalent Nonsense Mutation (W283X) and Two Novel Mutations in the Porphobilinogen Deaminase Gene of Swiss Patients with Acute Intermittent PorphyriaHuman Heredity, 2000
- Comprehensive Human Genetic Maps: Individual and Sex-Specific Variation in RecombinationThe American Journal of Human Genetics, 1998
- Molecular Epidemiology and Diagnosis of PBG Deaminase Gene Defects in Acute Intermittent PorphyriaThe American Journal of Human Genetics, 1997
- A metric map of humans: 23,500 loci in 850 bandsProceedings of the National Academy of Sciences, 1996
- Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase geneHuman Molecular Genetics, 1995
- Two novel mutations of the porphobilinogen deaminase gene in acute intermittent porphyriaHuman Molecular Genetics, 1993
- Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria.Journal of Clinical Investigation, 1990